Your browser doesn't support javascript.
loading
The CXCL10/CXCR3 Pathway Contributes to the Synergy of Thermal Ablation and PD-1 Blockade Therapy against Tumors.
Xiao, Wenlu; Huang, Hao; Zheng, Panpan; Liu, Yingting; Chen, Yaping; Chen, Junjun; Zheng, Xiao; Chen, Lujun; Jiang, Jingting.
Afiliação
  • Xiao W; Department of Tumor Biological Treatment, Jiangsu Engineering Research Center for Tumor Immunotherapy, Institute of Cell Therapy, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
  • Huang H; Department of Tumor Biological Treatment, Jiangsu Engineering Research Center for Tumor Immunotherapy, Institute of Cell Therapy, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
  • Zheng P; Department of Tumor Biological Treatment, Jiangsu Engineering Research Center for Tumor Immunotherapy, Institute of Cell Therapy, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
  • Liu Y; Department of Tumor Biological Treatment, Jiangsu Engineering Research Center for Tumor Immunotherapy, Institute of Cell Therapy, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
  • Chen Y; State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210016, China.
  • Chen J; Department of Tumor Biological Treatment, Jiangsu Engineering Research Center for Tumor Immunotherapy, Institute of Cell Therapy, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
  • Zheng X; Department of Tumor Biological Treatment, Jiangsu Engineering Research Center for Tumor Immunotherapy, Institute of Cell Therapy, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
  • Chen L; Department of Tumor Biological Treatment, Jiangsu Engineering Research Center for Tumor Immunotherapy, Institute of Cell Therapy, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
  • Jiang J; Department of Tumor Biological Treatment, Jiangsu Engineering Research Center for Tumor Immunotherapy, Institute of Cell Therapy, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
Cancers (Basel) ; 15(5)2023 Feb 23.
Article em En | MEDLINE | ID: mdl-36900218

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article